Author/Year of report | Sex Age | Concomitant AML | Treatment | Response/Status |
---|---|---|---|---|
King et al./1987 | F/36 | No | Radiotherapy + CT (Daunorubicin, Cytarabine, Thioguanine) | CR |
Moreau et al./1996 | M/32 | No | Duodenopancreatectomy + CT (Idarubin, Cytarabine) | CR after 2 years follow-up |
Marcos et al./1997 | F/37 | Yes | None | Died after initial MRI |
Ravandi - Kashani et al./1999 | M/31 | Yes | CT (Idarubicin, Cytarabine, All-trans retinoic acid) | CR, (follow-up unknown) |
F/61 | Yes | CT (Idarubicin, Cytarabine, Lisofylline) | Recurrence, died | |
Servin-Abad et al./2003 | M/64 | In remission | CT (Unknown regimen) | CR, died of stroke |
Breccia et al./2003 | F/42 | Yes | CT (Cytosine, Arabinoside, Idarubicin)+ BM allogarft | CR at 49 months from graft |
Schäfer et al./2008 | F/75 | Yes | CT (Etoposide, Cytarabine, reduced dose Mitoxantrone) | Recurrence (7 months), died |
Rong/2010 | M/40 | No | Duodenopancreatectomy + CT (Cytarabine based regimen) | CR, (follow-up unknown) |
Li et al./2011 | F/48 | No | Distal pancreatectomy + splenectomy, patient refused adjuvant CT | Recurrence (2 months), died 3 months after surgery |
Our study/2011 | F/45 | No | CT after duodenopancreatectomy (Cisplatin, Aracytine, Dexamethasone) | Early recurrence, died |
F/19 | No | CT (Aracytine based regimen) | Recurrence (8 months), alive after BM transplantation (22 months follow-up) |